Uncarboxylated osteocalcin stimulates 25-hydroxy vitamin D production in Leydig cell line through a GPRC6a-dependent pathway

Endocrinology (United States)

Volumn 155, Issue 11, 2014, Pages 4266-4274

  De Toni, Luca ^a   De Filippis, Vincenzo ^a   Tescari, Simone ^a   Ferigo, Marco ^a   Ferlin, Alberto ^a   Scattolini, Valentina ^a   Avogaro, Angelo ^a   Vettor, Roberto ^a   Foresta, Carlo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CHORIONIC GONADOTROPIN; CYTOCHROME P450; CYTOCHROME P450 2R1; ESTRADIOL; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 6A; LUTEINIZING HORMONE RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; OSTEOCALCIN; SEX HORMONE BINDING GLOBULIN; UNCLASSIFIED DRUG; 25-HYDROXYVITAMIN D; CARBON DIOXIDE; CARBOXYL RADICAL; CHOLESTANETRIOL 26 MONOOXYGENASE; CYP2R1 PROTEIN, MOUSE; GPRC6A PROTEIN, MOUSE; VITAMIN D;

ADULT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; DECARBOXYLATION; DOSE RESPONSE; GLUCOSE INTOLERANCE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; LEYDIG CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; SECOND MESSENGER; VITAMIN D METABOLISM; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CASE CONTROL STUDY; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; ANIMALS; CARBON DIOXIDE; CASE-CONTROL STUDIES; CELL LINE; CHOLESTANETRIOL 26-MONOOXYGENASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; LEYDIG CELLS; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MIDDLE AGED; OSTEOCALCIN; RECEPTORS, G-PROTEIN-COUPLED; VITAMIN D;

EID: 84908043042     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1283     Document Type: Article

References (32)

1. Ferlin A, Selice R, Carraro U, Foresta C. Testicular function and bone metabolism-beyond testosterone. Nat Rev Endocrinol. 2013;9:548-554.
2. Harada S, Rodan GA. Control of osteoblast function and regulation of bone mass. Nature. 2003;423:349-355.
3. Manolagas SC, Kousteni S, Jilka RL. Sex steroids and bone. Recent Prog Horm Res. 2002;57:385-409.
4. Khosla S, Melton LJ 3rd, Atkinson EJ, O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab. 2001;86:3555-3561.
5. Zimmermann S, Steding G, Emmen JM, et al. Targeted disruption of the Insl3 gene causes bilateral cryptorchidism. Mol Endocrinol. 1999;13:681-691.
6. Ferlin A, Pepe A, Gianesello L, et al. Mutations in the insulin-like factor 3 receptor are associated with osteoporosis. J Bone Miner Res. 2008;23:683-693.
7. Ferlin A, Perilli L, Gianesello L, Taglialavoro G, Foresta C. Profiling insulin like factor 3 (INSL3) signaling in human osteoblasts. PLoS One. 2011;6:e29733.
8. Foresta C, Strapazzon G, De Toni L, et al. Bone mineral density and testicular failure: evidence for a role of vitamin D 25-hydroxylase in human testis. J Clin Endocrinol Metab. 2011;96:E646-E652.
9. Strushkevich N, Usanov SA, Plotnikov AN, Jones G, Park HW. Structural analysis of CYP2R1 in complex with vitamin D3. J Mol Biol. 2008;380:95-106.
10. Fu GK, Lin D, Zhang MY, et al. Cloning of human 25-hydroxyvitamin D-1 α-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol Endocrinol. 1997;11:1961-1970.
11. Choudhary D, Jansson I, Stoilov I, Sarfarazi M, Schenkman JB. Expression patterns of mouse and human CYP orthologs (families 1-4) during development and in different adult tissues. Arch Biochem Biophys. 2005;436:50-61.
12. Zhu JG, Ochalek JT, Kaufmann M, Jones G, Deluca HF. CYP2R1 is a major, but not exclusive, contributor to 25-hydroxyvitamin D production in vivo. Proc Natl Acad Sci USA. 2013;110:15650-15655.
13. Foresta C, Selice R, De Toni L, et al. Altered bone status in unilateral testicular cancer survivors: role of CYP2R1 and its luteinizing hormone-dependency. J Endocrinol Invest. 2013;36:379-384.
14. Oury F, Sumara G, Sumara O, et al. Endocrine regulation of male fertility by the skeleton. Cell. 2011;144:796-809.
15. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456-469.
16. Pi M, Faber P, Ekema G, et al. Identification of a novel extracellular cation-sensing G-protein-coupled receptor. J Biol Chem. 2005;280:40201-40209.
17. Pi M, Chen L, Huang MZ, et al. GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome. PLoS One. 2008;3:e3858.
18. Poser JW, Price PA. A method for decarboxylation of γ-carboxyglutamic acid in proteins. Properties of the decarboxylated γ-carboxyglutamic acid protein from calf bone. J Biol Chem. 1979;254:431-436.
19. Ascoli M. Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses. Endocrinology. 1981;108:88-95.
20. Foresta C, Strapazzon G, De Toni L, et al. Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab. 2010;95:3502-3506.
21. Migliaccio S, Francomano D, Bruzziches R, et al. Trunk fat negatively influences skeletal and testicular functions in obese men: clinical implications for the aging male. Int J Endocrinol. 2013;10.1155/2013/182753.
22. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA. 2004;101:7711-7715.
23. Bièche I, Narjoz C, Asselah T, et al. Reverse transcriptase-PCR quantification of mRNA levels from cytochrome (CYP)1, CYP2 and CYP3 families in 22 different human tissues. Pharmacogenet Genomics. 2007;17:731-742.
24. Blomberg Jensen M, Nielsen JE, et al. Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod. 2010;25:1303-1311.
25. Wellendorph P, Bräuner-Osborne H. Molecular cloning, expression, and sequence analysis of GPRC6A,a novel family CG-protein coupled receptor. Gene. 2004;335:37-46.
26. Díaz-López A, Bulló M, Juanola-Falgarona M, et al. Reduced serum concentrations of carboxylated and undercarboxylated osteocalcin are associated with risk of developing type 2 diabetes mellitus in a high cardiovascular risk population: a nested case-control study. J Clin Endocrinol Metab. 2013;98:4524-4531.
27. Hannemann A, Breer S, Wallaschofski H, et al. Osteocalcin is associated with testosterone in the general population and selected patients with bone disorders. Andrology. 2013;1:469-474.
28. Oury F, Ferron M, Huizhen W, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest. 2013;123:2421-2433.
29. Costa RR, Varanda WA. Intracellular calcium changes in mice Leydig cells are dependent on calcium entry through T-type calcium channels. J Physiol. 2007;585:339-349.
30. Oya M, Kitaguchi T, Pais R, Reimann F, Gribble F, Tsuboi T. The G protein-coupled receptor family C group 6 subtype A (GPRC6A) receptor is involved in amino acid-induced glucagon-like peptide-1 secretion from GLUTag cells. J Biol Chem. 2013;288:4513-4521.
31. Jacobsen SE, Nørskov-Lauritsen L, Thomsen AR, et al. Delineation of the GPRC6A receptor signaling pathways using a mammalian cell line stably expressing the receptor. J Pharmacol Exp Ther. 2013;347:298-309.
32. Heaney RP, Recker RR, Grote J, Horst RL, Armas LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab. 2011;96:E447-E452.